期刊文献+

基于端粒G-四链体受体构建具有抗肿瘤功效的药效团模型 被引量:1

Structure based pharmacophore modelling of telomeric G-quadruplex for anti-tumor
原文传递
导出
摘要 端粒G-四链体DNA是由端粒末端富含鸟嘌呤的DNA序列通过自身组装形成的一种特殊的二级结构。配体通过结合/稳定端粒G-四链体DNA可以抑制端粒酶延长端粒DNA,从而抑制了癌细胞赖以生存的端粒维持机制。本文运用Discovery Studio3.5软件中的Structure Based Pharmacophore(SBP)方法,以分子间端粒G-四链体DNA四聚体的结构为基础,构建了具有抗肿瘤功效的药效团模型。并通过分析测试集与药效团模型的匹配情况,对模型进行了验证。证明了该模型的正确性和可靠性,此药效团模型可用于天然产物数据库的高通量虚拟筛选。 Telomeric G-quadruplex DNA is a kind of special DNA secondary structure formed by self-assembly of the guanine-rich sequence at the end of the telomere. Telomeric G-quadruplex ligands could inhibit the telomerase from extending the telomere through specifically binding and stabilizing this structure,thus interfering with the telomere maintenance of cancer cells which is crucial for their survival. The pharmacophore model for antitumor was constructed by Structure Based Pharmacophore (SBP) of Discovery Studio 3.5, based on the quartemary structure of intermolecular telomeric G-quadruplex DNA. By means of the matching condition analysis between test set and the pharmacophore model, the validity and reliability of the model was verified. The result indicated that the pharmacophore model can be used in the high throughput virtual screening of natural products database.
出处 《计算机与应用化学》 CAS 2016年第3期369-372,共4页 Computers and Applied Chemistry
基金 中央民族大学一流大学一流学科建设项目(YDLX01013)
关键词 药效团模型 端粒G-四链体 抗肿瘤 计算机辅助药物设计 pharmacophore model telomeric G-quadruplex anti-tumor CADD
  • 相关文献

参考文献18

  • 1Shirude P S, Okumus B, Ying L, et al. Single-molecule conformational analysis of G-quadruplex formation in the promoter DNA duplex of the proto-oncogene c-kit[J]. Journal of the American Chemical Society, 2007, 129(24):7484-7485.
  • 2Guo K, Gokhale V, Hurley L H, et al. Intra-molecularly folded G-quadruplex and i-motif structures in the proximal promoter of the vascular endothelialgrowth factor gene[J]. Nucleic Acids Res, 2008, 36(14):4598-4608.
  • 3Patel D J, Modi Y S, Phan A T. Propeller-type parallel-stranded g-quadruplexes in the human c-myc promoter[J]. Journal of the American Chemical Society Jacs, 2004, 126:8710-8716.
  • 4Dai J, Chen D, Jones R A, et al. NMR solution structure of the major G-quadruplex structure formed in the human BCL2 promoter region[J]. Nucleic Acids Research, 2006, 34:5133-5144.
  • 5Pt D C, Lacroix-L, Douarre C, et al. Targeting telomeres and telomerase[J]. Biochimie, 2008, 90( 1 ):573-590, IN 1, 591-592.
  • 6李燕梅,沈晓燕.具抑制端粒酶活性的G-四链体小分子配体研究进展[J].中国药理学通报,2010,26(1):17-20. 被引量:3
  • 7Monchaud D, Teulade-Fichou M. A hitchhiker's guide to G-quadruplex ligands[J]. Organic Biomolecular Chemistry, 2008, 4:627-636.
  • 8Ou T M, Lu Y J, Tan J H, et al. G-quadruplexes: targets in anticancer drug design[J]. Chemmedchem, 2008, 3(5):690-713.
  • 9Moore M J, Schultes C M, Cuesta J, et al. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation[J]. Journal of Medicinal Chemistry, 2006, 49(2):582-599.
  • 10Gowan S M, Harrison J R, Patterson L, et al. A G-quadruplex- interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity[J]. Molecular Pharmacology, 2002, 61 (5):1154-1162.

二级参考文献28

共引文献60

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部